These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 17726064

  • 1. Nucleocytoplasmic shuttling of persistently activated STAT3.
    Herrmann A, Vogt M, Mönnigmann M, Clahsen T, Sommer U, Haan S, Poli V, Heinrich PC, Müller-Newen G.
    J Cell Sci; 2007 Sep 15; 120(Pt 18):3249-61. PubMed ID: 17726064
    [Abstract] [Full Text] [Related]

  • 2. PIAS3, SHP2 and SOCS3 Expression patterns in Cervical Cancers: Relevance with activation and resveratrol-caused inactivation of STAT3 signaling.
    Zhang P, Yang B, Yao YY, Zhong LX, Chen XY, Kong QY, Wu ML, Li C, Li H, Liu J.
    Gynecol Oncol; 2015 Dec 15; 139(3):529-35. PubMed ID: 26432044
    [Abstract] [Full Text] [Related]

  • 3. Stimulation of the JAK/STAT pathway by LIF and OSM in the human granulosa cell line COV434.
    Pastuschek J, Poetzsch J, Morales-Prieto DM, Schleußner E, Markert UR, Georgiev G.
    J Reprod Immunol; 2015 Apr 15; 108():48-55. PubMed ID: 25817464
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The JAK-inhibitor, JAB/SOCS-1 selectively inhibits cytokine-induced, but not v-Src induced JAK-STAT activation.
    Iwamoto T, Senga T, Naito Y, Matsuda S, Miyake Y, Yoshimura A, Hamaguchi M.
    Oncogene; 2000 Sep 28; 19(41):4795-801. PubMed ID: 11032030
    [Abstract] [Full Text] [Related]

  • 6. SHP2, SOCS3 and PIAS3 Expression Patterns in Medulloblastomas: Relevance to STAT3 Activation and Resveratrol-Suppressed STAT3 Signaling.
    Li C, Li H, Zhang P, Yu LJ, Huang TM, Song X, Kong QY, Dong JL, Li PN, Liu J.
    Nutrients; 2016 Dec 27; 9(1):. PubMed ID: 28035977
    [Abstract] [Full Text] [Related]

  • 7. Tyrosine phosphorylation of estradiol receptor by Src regulates its hormone-dependent nuclear export and cell cycle progression in breast cancer cells.
    Castoria G, Giovannelli P, Lombardi M, De Rosa C, Giraldi T, de Falco A, Barone MV, Abbondanza C, Migliaccio A, Auricchio F.
    Oncogene; 2012 Nov 15; 31(46):4868-77. PubMed ID: 22266855
    [Abstract] [Full Text] [Related]

  • 8. The role of the N-terminal domain in dimerization and nucleocytoplasmic shuttling of latent STAT3.
    Vogt M, Domoszlai T, Kleshchanok D, Lehmann S, Schmitt A, Poli V, Richtering W, Müller-Newen G.
    J Cell Sci; 2011 Mar 15; 124(Pt 6):900-9. PubMed ID: 21325026
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Expression of STATs and their inhibitors SOCS and PIAS in brain tumors. In vitro and in vivo study.
    Ehrmann J, Strakova N, Vrzalikova K, Hezova R, Kolar Z.
    Neoplasma; 2008 Mar 15; 55(6):482-7. PubMed ID: 18999875
    [Abstract] [Full Text] [Related]

  • 13. Phosphorylation of signal transducer and activator of transcription 3 in soft tissue leiomyosarcoma is associated with a better prognosis.
    Setsu N, Kohashi K, Endo M, Yamamoto H, Tamiya S, Takahashi Y, Yamada Y, Ishii T, Matsuda S, Yokoyama R, Iwamoto Y, Oda Y.
    Int J Cancer; 2013 Jan 01; 132(1):109-15. PubMed ID: 22644781
    [Abstract] [Full Text] [Related]

  • 14. Oxidative stress impairs multiple regulatory events to drive persistent cytokine-stimulated STAT3 phosphorylation.
    Ng IH, Yeap YY, Ong LS, Jans DA, Bogoyevitch MA.
    Biochim Biophys Acta; 2014 Mar 01; 1843(3):483-94. PubMed ID: 24286865
    [Abstract] [Full Text] [Related]

  • 15. Brassinin inhibits STAT3 signaling pathway through modulation of PIAS-3 and SOCS-3 expression and sensitizes human lung cancer xenograft in nude mice to paclitaxel.
    Lee JH, Kim C, Sethi G, Ahn KS.
    Oncotarget; 2015 Mar 20; 6(8):6386-405. PubMed ID: 25788267
    [Abstract] [Full Text] [Related]

  • 16. The association and nuclear translocation of the PIAS3-STAT3 complex is ligand and time dependent.
    Dabir S, Kluge A, Dowlati A.
    Mol Cancer Res; 2009 Nov 20; 7(11):1854-60. PubMed ID: 19903771
    [Abstract] [Full Text] [Related]

  • 17. Characterization of the SOCS3 promoter response to prostaglandin E2 in T47D cells.
    Barclay JL, Anderson ST, Waters MJ, Curlewis JD.
    Mol Endocrinol; 2007 Oct 20; 21(10):2516-28. PubMed ID: 17636039
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Correlative analyses of the expression levels of PIAS3, p-SHP2, SOCS1 and SOCS3 with STAT3 activation in human astrocytomas.
    Liu LH, Li H, Cheng XX, Kong QY, Chen XY, Wu ML, Li Y, Liu J, Li C.
    Mol Med Rep; 2017 Feb 20; 15(2):847-852. PubMed ID: 28035384
    [Abstract] [Full Text] [Related]

  • 20. Repression of Stat3 activity by activation of mitogen-activated protein kinase (MAPK).
    Jain N, Zhang T, Fong SL, Lim CP, Cao X.
    Oncogene; 1998 Dec 17; 17(24):3157-67. PubMed ID: 9872331
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.